Not applicableStudy completedNCT02756481
What this trial is testing
Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela
Who this might be right for
Non-Valvular Atrial Fibrillation
Bristol-Myers Squibb 80